María José Méndez-Vidal
7PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.Robert J Motzer, Camillo Porta, Masatoshi Eto
|Nov 14, 2023
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.María José Juan Fita, Urbano Anido Herranz, María José Mendez-Vidal
|Aug 09, 2023
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).María José Méndez-Vidal, Martin Lázaro Quintela, Nuria Lainez-Milagro
|Mar 22, 2023
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida
|Feb 22, 2023
Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).Cristina Suárez, James M G Larkin, Poulam Patel
|Jun 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida
Pageof 2
Frequent Collaborators
5 joint publications
Thomas Powles
4 joint publications
Aaron Prendergast
3 joint publications
Simon J Crabb
3 joint publications
Urbano Anido Herranz
3 joint publications
Andrew Protheroe
3 joint publications
Pieter-Jan van Dam
3 joint publications
Joy S Tea
1 joint publications
James M G Larkin
1 joint publications
Alejo Rodriguez-Vida
1 joint publications
Hilary Glen
